
It seems that thanks to specialized stock marketing letters and opposed to yesterday's 5.56% pulling back, GETA shares will add value and volume these days.
Since the end of June, the bio-pharmaceutical GETA stock is presented in stock marketing letters as the OTC major gainer.
GETA shares are stock promotion sensitive. As chart here shows, the campaign this April brings positive results for GETA stock performance. Only the rapid drop down of the price afterward was not so positive for investors.
For more than two weeks there are no official company's announcements related to its products development or material interests.
The last significant information about GETA is from the middle of June.
During the Annual Meeting of Stockholders, one of the matters voted was the authorization to effect a reverse stock split of GETA's outstanding common stock at any ratio up to 1-for-100.

Looks, like GETA will be a real gainer these days.
